Literature DB >> 25337412

Dosimetric effect of tissue heterogeneity for (125)I prostate implants.

Susana Maria Oliveira1, Nuno José Teixeira2, Lisete Fernandes3, Pedro Teles4, Pedro Vaz4.   

Abstract

AIM: To use Monte Carlo (MC) together with voxel phantoms to analyze the tissue heterogeneity effect in the dose distributions and equivalent uniform dose (EUD) for (125)I prostate implants.
BACKGROUND: Dose distribution calculations in low dose-rate brachytherapy are based on the dose deposition around a single source in a water phantom. This formalism does not take into account tissue heterogeneities, interseed attenuation, or finite patient dimensions effects. Tissue composition is especially important due to the photoelectric effect.
MATERIALS AND METHODS: The computed tomographies (CT) of two patients with prostate cancer were used to create voxel phantoms for the MC simulations. An elemental composition and density were assigned to each structure. Densities of the prostate, vesicles, rectum and bladder were determined through the CT electronic densities of 100 patients. The same simulations were performed considering the same phantom as pure water. Results were compared via dose-volume histograms and EUD for the prostate and rectum.
RESULTS: The mean absorbed doses presented deviations of 3.3-4.0% for the prostate and of 2.3-4.9% for the rectum, when comparing calculations in water with calculations in the heterogeneous phantom. In the calculations in water, the prostate D 90 was overestimated by 2.8-3.9% and the rectum D 0.1cc resulted in dose differences of 6-8%. The EUD resulted in an overestimation of 3.5-3.7% for the prostate and of 7.7-8.3% for the rectum.
CONCLUSIONS: The deposited dose was consistently overestimated for the simulation in water. In order to increase the accuracy in the determination of dose distributions, especially around the rectum, the introduction of the model-based algorithms is recommended.

Entities:  

Keywords:  AAPM TG, American Association of Physicists in Medicine Task Group; Brachytherapy; CT, computerized tomography; DVH, dose–volume histogram; EBRT, external beam radiotherapy; EUD, equivalent uniform dose; HT, heterogeneous; LDRBT, low dose-rate brachytherapy; MBDCA, model-based dose calculation algorithm; MC, Monte Carlo; Model-based calculation algorithms; Monte Carlo; NTCP, normal tissue complication probability; OAR, organ at risk; PS, planning system; Prostate cancer; TCP, tumor control probability (TCP); Tissue heterogeneity; W, water; dDVH, differential dose–volume histogram

Year:  2014        PMID: 25337412      PMCID: PMC4201780          DOI: 10.1016/j.rpor.2014.03.004

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN: 1507-1367


  29 in total

1.  Dosimetric effects of seed anisotropy and interseed attenuation for 103Pd and 125I prostate implants.

Authors:  Omar Chibani; Jeffrey F Williamson; Dorin Todor
Journal:  Med Phys       Date:  2005-08       Impact factor: 4.071

2.  Monte Carlo and experimental dosimetry of an 1251 brachytherapy seed.

Authors:  James Dolan; Zuofeng Lia; Jeffrey F Williamson
Journal:  Med Phys       Date:  2006-12       Impact factor: 4.071

3.  A new formula for normal tissue complication probability (NTCP) as a function of equivalent uniform dose (EUD).

Authors:  Gary Luxton; Paul J Keall; Christopher R King
Journal:  Phys Med Biol       Date:  2007-12-13       Impact factor: 3.609

4.  Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method.

Authors:  G J Kutcher; C Burman
Journal:  Int J Radiat Oncol Biol Phys       Date:  1989-06       Impact factor: 7.038

5.  AAPM recommendations on dose prescription and reporting methods for permanent interstitial brachytherapy for prostate cancer: report of Task Group 137.

Authors:  Ravinder Nath; William S Bice; Wayne M Butler; Zhe Chen; Ali S Meigooni; Vrinda Narayana; Mark J Rivard; Yan Yu
Journal:  Med Phys       Date:  2009-11       Impact factor: 4.071

6.  Cell kinetic measurements in prostate cancer.

Authors:  K M Haustermans; I Hofland; H Van Poppel; R Oyen; W Van de Voorde; A C Begg; J F Fowler
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-03-15       Impact factor: 7.038

7.  Updated Solid Water to water conversion factors for 125I and l03Pd brachytherapy sources.

Authors:  Ali S Meigooni; Shahid B Awan; Nathan S Thompson; Sharifeh A Dini
Journal:  Med Phys       Date:  2006-11       Impact factor: 4.071

Review 8.  What do we know about the α/β for prostate cancer?

Authors:  S M Oliveira; N J Teixeira; L Fernandes
Journal:  Med Phys       Date:  2012-06       Impact factor: 4.071

9.  Fitting late rectal bleeding data using different NTCP models: results from an Italian multi-centric study (AIROPROS0101).

Authors:  T Rancati; C Fiorino; G Gagliardi; G M Cattaneo; G Sanguineti; V Casanova Borca; C Cozzarini; G Fellin; F Foppiano; G Girelli; L Menegotti; A Piazzolla; V Vavassori; R Valdagni
Journal:  Radiother Oncol       Date:  2004-10       Impact factor: 6.280

10.  Subcellular concentrations of calcium, zinc, and magnesium in benign nodular hyperplasia of the human prostate: X-ray microanalysis of freeze-dried cryosections.

Authors:  K E Tvedt; G Kopstad; O A Haugen; J Halgunset
Journal:  Cancer Res       Date:  1987-01-01       Impact factor: 12.701

View more
  6 in total

1.  Evaluation of hypothetical (153)Gd source for use in brachytherapy.

Authors:  Mahdi Ghorbani; Marziyeh Behmadi
Journal:  Rep Pract Oncol Radiother       Date:  2015-06-27

2.  Experimental set up for the irradiation of biological samples and nuclear track detectors with UV C.

Authors:  Agustina Mariana Portu; Andrés Eugenio Rossini; Mario Alberto Gadan; Omar Alberto Bernaola; Silvia Inés Thorp; Paula Curotto; Emiliano César Cayetano Pozzi; Rómulo Luis Cabrini; Gisela Saint Martin
Journal:  Rep Pract Oncol Radiother       Date:  2014-11-04

3.  Film based verification of calculation algorithms used for brachytherapy planning-getting ready for upcoming challenges of MBDCA.

Authors:  Grzegorz Zwierzchowski; Grzegorz Bielęda; Janusz Skowronek; Magdalena Mazur
Journal:  J Contemp Brachytherapy       Date:  2016-08-16

4.  Determination of dosimetric parameters for shielded 153Gd source in prostate cancer brachytherapy.

Authors:  Mahdi Ghorbani; Benyamin Khajetash; Najmeh Ghatei; Mohammad Mehrpouyan; Ali S Meigooni; Ramin Shahraini
Journal:  Radiol Oncol       Date:  2017-02-22       Impact factor: 2.991

5.  Determination of TG-43 Dosimetric Parameters for Photon Emitting Brachytherapy Sources.

Authors:  Mozaffari A; Ghorbani M
Journal:  J Biomed Phys Eng       Date:  2019-08-01

6.  Quality Assurance Procedures based on Dosimetric, Gamma Analysis as a Fast Reliable Tool for Commissioning Brachytherapy Treatment Planning Systems.

Authors:  Grzegorz Zwierzchowski; Grzegorz Bieleda; Janusz Skowronek
Journal:  Radiol Oncol       Date:  2017-11-29       Impact factor: 2.991

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.